COgnitive REhabilitation in Pediatric Patients With sABI From Vegetative State to Functional Recovery

  • End date
    Jul 1, 2023
  • participants needed
  • sponsor
    IRCCS Eugenio Medea
Updated on 3 September 2021
vegetative state
cognitive rehabilitation


Acquired brain lesions (GCLA) represent one of the most important cause of disability and mortality during the pediatric age, also in the western Countries. The important medical progresses of the last decade in the medical field have increased the percentages of survival, also in the most severe clinical pictures. On the other hand, a brain lesion reported in the first years of life presents with a more dramatic impact on the cognitive and neurological development of the patients and it can significantly interfere with the same quality of their life. Recent studies suggest that a brain damage in this stage of the life is related to more persistent sequelae in comparison of the same lesion reported by an adult patient, because of the neurological immaturity at the moment of the insult. Furthermore, in most cases, the brain lesion is related not only to motor and sensorial deficits but also to very important behavioral and cognitive problems, that can arise immediately after the acute phase, or also several years after the pathological event.


The aims of the present study are:

  1. To contribute to the adaptation of the Italian version of the Coma Recovery Scale (CRS-R) for the pediatric age, with specific differentiation and taking into account the age of the patients and the specific learning that characterize each developmental stage;
  2. As regards the patients with an adequate cognitive profile, to compare the effectiveness of a traditional multifunction neuropsychological treatment (cognitive functions are stimulated at the same time) vs a sequential treatment (cognitive functions are stimulated step by step).

Condition Child Development, Brain Injury, brain damage, brain damages, cerebral injury, acquired brain injury
Treatment Neuropsychological treatment
Clinical Study IdentifierNCT04499092
SponsorIRCCS Eugenio Medea
Last Modified on3 September 2021


Yes No Not Sure

Inclusion Criteria

For the adaptation of the CRS-R
Healthy subjects
children aged between 0 and 5 years (N=48)
normal development
Clinical subjects
Age between 0 and 10 at the moment of the pathological event
LOCFAS score <5
A documented diagnosis of severe acquired brain lesion of traumatic, anoxic, vascular or infective etiology (Glasgow Coma Scale, GCS<12)
Brain lesion reported within one year from the day of the inclusion in the study
For the comparison between multifunction treatment vs sequential treatment
Age between 5 and 18 years at the moment of the pathological event
LOCFAS score>5
time between the GCLA and the assessment < 3 months
Documented GCLA
GCS <12 in the acute phase
Negative anamnesis for other developmental disorders before the GCLA
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note